Crossref
Immuno-nanoinhibitor potentiates molecular targeted therapy of T-cell acute lymphoblastic leukemia
Science China Technological Sciences · 2026-07 · 69 (7)
DOI: 10.1007/s11431-025-3277-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science China Technological Sciences, online erschienen am 17.06.2026. Verfasst von Chenming Li und 5 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, C., Zhai, Z., Chen, L., Cao, L., Sun, H., & Zhong, Z. (2026). Immuno-nanoinhibitor potentiates molecular targeted therapy of T-cell acute lymphoblastic leukemia. Science China Technological Sciences, 69(7). https://doi.org/10.1007/s11431-025-3277-2
Vancouver
Li C, Zhai Z, Chen L, Cao L, Sun H, Zhong Z. Immuno-nanoinhibitor potentiates molecular targeted therapy of T-cell acute lymphoblastic leukemia. Science China Technological Sciences. 2026;69(7). doi:10.1007/s11431-025-3277-2
BibTeX
@article{Li2026,
author = {Li, Chenming and Zhai, Zhenzhen and Chen, Lin and Cao, Li and Sun, Huanli and Zhong, Zhiyuan},
title = {Immuno-nanoinhibitor potentiates molecular targeted therapy of T-cell acute lymphoblastic leukemia},
journal = {Science China Technological Sciences},
year = {2026},
volume = {69},
number = {7},
doi = {10.1007/s11431-025-3277-2}
}
EUVIMED